Pfizer Inc. (NYSE:PFE)

A transition from substantial economic value creation to consistent value destruction is observed over the analyzed period. While a peak in economic profitability was achieved in 2022, subsequent years indicate a failure to generate returns that exceed the cost of capital, signaling a decline in overall financial efficiency.

Net Operating Profit After Taxes (NOPAT)

Significant volatility is evident in operating performance, with NOPAT peaking at US$ 31,018 million in 2022 before experiencing a sharp contraction to a deficit of US$ 1,277 million in 2023. Although a recovery was recorded in 2024 and 2025, the figures stabilized at a much lower level, approximately US$ 7,200 million, which represents a substantial decrease from the 2021-2022 levels.

Invested Capital and Cost of Capital

Invested capital showed a marked upward trend, increasing from US$ 87,670 million in 2021 to a peak of US$ 154,882 million in 2023. This expansion of the capital base occurred simultaneously with the sharpest decline in NOPAT, suggesting a misalignment between capital deployment and profit generation during that period. The cost of capital remained relatively stable, fluctuating marginally between 8.50% and 9.84%.

Economic Profit Analysis

Economic profit transitioned from a strong positive of US$ 20,119 million in 2022 to a deep negative of US$ 14,449 million in 2023. Despite a reduction in the deficit by 2024, the economic profit remained negative through 2025. This trend indicates that the entity's return on invested capital has remained below its cost of capital for three consecutive years, resulting in a continuous erosion of economic value.

Net income attributable to Pfizer Inc. common shareholders and Net Operating Profit After Taxes (NOPAT) exhibited significant fluctuations between 2021 and 2025. While net income demonstrated an initial increase followed by a substantial decline, NOPAT mirrored this pattern with even more pronounced volatility, including a negative value in 2023.

Net Income Trend

Net income attributable to Pfizer Inc. common shareholders increased from US$21,979 million in 2021 to US$31,372 million in 2022, representing a substantial year-over-year growth. However, a dramatic decrease was observed in 2023, falling to US$2,119 million. A partial recovery occurred in 2024, with net income reaching US$8,031 million, followed by a slight decrease to US$7,771 million in 2025.

NOPAT Trend

NOPAT followed a similar trajectory to net income, increasing from US$18,394 million in 2021 to US$31,018 million in 2022. A significant shift occurred in 2023, with NOPAT becoming negative at US$-1,277 million. A recovery was then seen in 2024, rising to US$7,374 million, and continuing to US$7,193 million in 2025. The magnitude of the decline and subsequent recovery in NOPAT was greater than that observed in net income.

Relationship between Net Income and NOPAT

While both metrics generally moved in the same direction, the divergence in 2023 is noteworthy. The substantial negative NOPAT value suggests that operating profits, after accounting for taxes, were insufficient to cover the cost of capital employed during that year, despite a positive, albeit significantly reduced, net income. This indicates that factors beyond core operational profitability, such as financing or non-operating items, played a larger role in determining net income in 2023.

The period between 2024 and 2025 shows relative stabilization in both metrics, although NOPAT remains considerably lower than its peak in 2022. Further investigation would be required to understand the underlying drivers of these fluctuations and their implications for the company’s long-term financial performance.

The provision for taxes on income exhibits significant volatility over the observed period. Beginning at US$1,852 million in 2021, it increased substantially to US$3,328 million in 2022 before experiencing a dramatic shift to a benefit of negative US$1,115 million in 2023. This benefit continued, albeit at a smaller magnitude, in 2024 (-US$28 million) and 2025 (-US$267 million). In contrast, cash operating taxes demonstrate a more stable, though fluctuating, pattern.

Cash Operating Taxes Trend

Cash operating taxes increased from US$6,137 million in 2021 to US$7,967 million in 2022, representing a substantial rise. A subsequent decrease was noted in 2023, falling to US$2,113 million. Values then recovered somewhat in 2024 and 2025, reaching US$2,426 million and US$2,334 million respectively. While fluctuating, the values in 2024 and 2025 remain considerably below the 2021 and 2022 levels.

The divergence between the provision for taxes on income and cash operating taxes is noteworthy. The large benefit recorded in the provision for taxes in 2023, 2024, and 2025 suggests the utilization of tax loss carryforwards or other tax planning strategies, resulting in a reduced accounting expense despite continued cash outflows for taxes. The cash operating taxes, while decreasing from 2022 to 2023, remained positive throughout the period, indicating actual cash payments were made to tax authorities even when the accounting provision reflected a benefit.

Relationship between Provision and Cash Taxes

The difference between the provision for taxes on income and cash operating taxes widened considerably in 2023, 2024, and 2025. This indicates a growing deferral of taxable income or an increasing benefit from tax credits or loss carryforwards. The substantial difference highlights the impact of non-cash tax items on the reported income tax expense.

The observed trends suggest a complex tax position, potentially involving significant tax planning and the utilization of deferred tax assets. Further investigation into the specific drivers of the tax benefit and the nature of the deferred tax items would be beneficial for a complete understanding of the company’s tax strategy and its impact on financial performance.

The reported invested capital demonstrates a clear increasing trend over the observed period, followed by a stabilization and slight increase. A significant rise is noted between 2021 and 2023, while subsequent years show a more moderate pattern. This analysis details the observed movements in invested capital alongside its constituent components: total reported debt & leases and total shareholders’ equity.

Invested Capital Trend

Invested capital increased substantially from US$87,670 million in 2021 to US$154,882 million in 2023, representing a growth of approximately 76.8%. This growth slowed considerably in 2024, with invested capital decreasing to US$135,342 million. A modest increase to US$139,753 million was observed in 2025. The 2024 decrease suggests a potential shift in capital allocation strategy or a reduction in capital-intensive projects.

Debt & Leases

Total reported debt & leases decreased from US$41,395 million in 2021 to US$39,046 million in 2022. However, a substantial increase occurred in 2023, reaching US$75,041 million. This was followed by a decrease to US$66,993 million in 2024 and a slight increase to US$67,416 million in 2025. The 2023 surge in debt likely contributed significantly to the overall increase in invested capital during that year.

Shareholders’ Equity

Total shareholders’ equity increased from US$77,201 million in 2021 to US$95,661 million in 2022, indicating strong equity growth. A decrease was then observed in 2023, falling to US$89,014 million, and continued to decline in 2024 and 2025, reaching US$88,203 million and US$86,476 million respectively. This consistent decline in shareholders’ equity over the latter part of the period partially offset the impact of increased debt on invested capital.

The interplay between debt and equity significantly influences the overall invested capital. While debt increased substantially in 2023, the subsequent decrease in shareholders’ equity moderated the growth in invested capital in 2024 and 2025. The stabilization of invested capital in the later years suggests a balancing act between debt financing and equity returns.

The financial performance from 2021 to 2025 reveals significant volatility in value creation, characterized by an initial period of growth followed by a sustained transition into negative economic profit. The shift indicates a period where the returns on invested capital failed to exceed the required cost of capital.

Economic Profit and Spread Ratio Trends

A peak in economic profit was reached in 2022 at US$ 20,119 million, which aligned with a maximum economic spread ratio of 18.17%. This was followed by a severe contraction in 2023, where economic profit dropped to -US$ 14,449 million and the spread ratio plummeted to -9.33%. While there was a partial recovery in the spread ratio to -3.21% in 2024 and -3.53% in 2025, the company has remained in a state of value destruction, as the ratio has not returned to positive territory since 2022.

Invested Capital Dynamics

Invested capital experienced a steady increase between 2021 and 2023, rising from US$ 87,670 million to a peak of US$ 154,882 million. This expansion of the capital base coincided with the subsequent decline in the economic spread ratio, suggesting that the capital deployed during this growth phase did not generate sufficient returns to cover its cost. A subsequent reduction to US$ 135,342 million in 2024 and a slight increase to US$ 139,753 million in 2025 indicate a stabilization of the capital base following the 2023 peak.

Value Creation Synthesis

The trajectory demonstrates a transition from substantial value creation in the 2021-2022 period to persistent value erosion from 2023 through 2025. Although the magnitude of the economic loss decreased after the 2023 trough, the stabilization of the economic spread ratio at approximately -3.5% by 2025 highlights a continuing deficit between actual returns and the cost of capital.

The financial performance from 2021 to 2025 is characterized by a period of significant expansion followed by a sharp contraction and a subsequent phase of partial stabilization. A notable transition occurred between 2022 and 2023, where a peak in value creation shifted abruptly to significant value destruction.

Revenue Trends

Revenues experienced an upward trajectory, reaching a peak of 101,175 million US$ in 2022. This was followed by a substantial decline to 59,553 million US$ in 2023, representing a contraction of approximately 41%. From 2023 through 2025, revenues remained relatively stable, fluctuating within a narrow range between 59,553 million US$ and 63,627 million US$.

Economic Profit Volatility

Economic profit exhibited extreme volatility, doubling from 9,937 million US$ in 2021 to 20,119 million US$ in 2022. A severe reversal occurred in 2023, with economic profit falling to negative 14,449 million US$. Although losses narrowed to negative 4,348 million US$ in 2024 and negative 4,932 million US$ in 2025, the figures indicate a failure to return to positive economic profit following the 2022 peak.

Economic Profit Margin Analysis

The economic profit margin mirrored the volatility of absolute profits, rising from 12.10% in 2021 to 19.89% in 2022. A collapse to negative 24.26% in 2023 indicates a period where the cost of capital significantly exceeded operating returns. While the margin improved to negative 6.83% in 2024 and negative 7.88% in 2025, the sustained negative percentages confirm that the entity continues to generate returns below its required cost of capital.